Australian life science industry unites through COVID-19
Dr Craig Rayner|
President, Integrated Drug Development
Australia has been at the forefront of the global response to COVID-19 pandemic in development of vaccines, repurposing of medicines and manufacturing ventilators. This session will highlight the contribution Australia has made and continued role in the global response.
Therapeutics and personalized medicine: Evidence-based medicine and precision dosing
Dr Leigh Farrell|
Executive Advisor, Certara
Additional Speakers: Dr Michael Winlo, Chief Executive Officer, Emyria, Prof. Andrew McLachlan, Head of School & Dean of the University of Sydney School of Pharmacy